Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Kesselheim

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|April 22, 2011
Safety, supply, and suits--litigation and the vaccine industryAaron Kesselheim
Annals of Internal Medicine|April 20, 2011
A hemorrhage of off-label useJerry Avorn, Aaron Kesselheim
JAMA|September 2, 2020
Regulatory Decision-making on COVID-19 Vaccines During a Public Health EmergencyJerry Avorn, Aaron Kesselheim
JAMA Internal Medicine|February 7, 2017
Applying Academic Detailing and Process Change to Promote Choosing WiselyMichael Fralick, Aaron Kesselheim, Jerry Avorn
The New England Journal of Medicine|September 20, 2018
The FDA Amendments Act of 2007 - Assessing Its Effects a Decade LaterJerry Avorn, Aaron Kesselheim, Ameet Sarpatwari
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
INTRODUCTION: <b>Promoting Drug and Vaccine Innovation and Managing High Prices:</b> Introducing a Special SymposiumAaron Kesselheim, Ameet Sarpatwari, Benjamin Rome
Cleveland Clinic Journal of Medicine|February 1, 2006
Contrast-induced nephropathy: how it develops, how to prevent itMichael R Rudnick, Aaron Kesselheim, Stanley Goldfarb
JAMA Oncology|February 3, 2022
Characteristics of Clinical Trials Evaluating Biosimilars in the Treatment of Cancer: A Systematic Review and Meta-analysisDoni Bloomfield, Elvira D'Andrea, Sarosh Nagar, et al.
JAMA Network Open|October 12, 2019
Characteristics of Recent Generic Drug Approvals by the US Food and Drug AdministrationKuo Jiao, Ravi Gupta, Erin Fox, et al.
Journal of the National Cancer Institute|November 9, 2025
Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanomaDeirdre Weymann, Emanuel Krebs, Samantha Pollard, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|April 22, 2011
Safety, supply, and suits--litigation and the vaccine industryAaron Kesselheim
Annals of Internal Medicine|April 20, 2011
A hemorrhage of off-label useJerry Avorn, Aaron Kesselheim
JAMA|September 2, 2020
Regulatory Decision-making on COVID-19 Vaccines During a Public Health EmergencyJerry Avorn, Aaron Kesselheim
JAMA Internal Medicine|February 7, 2017
Applying Academic Detailing and Process Change to Promote Choosing WiselyMichael Fralick, Aaron Kesselheim, Jerry Avorn
The New England Journal of Medicine|September 20, 2018
The FDA Amendments Act of 2007 - Assessing Its Effects a Decade LaterJerry Avorn, Aaron Kesselheim, Ameet Sarpatwari
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
INTRODUCTION: <b>Promoting Drug and Vaccine Innovation and Managing High Prices:</b> Introducing a Special SymposiumAaron Kesselheim, Ameet Sarpatwari, Benjamin Rome
Cleveland Clinic Journal of Medicine|February 1, 2006
Contrast-induced nephropathy: how it develops, how to prevent itMichael R Rudnick, Aaron Kesselheim, Stanley Goldfarb
JAMA Oncology|February 3, 2022
Characteristics of Clinical Trials Evaluating Biosimilars in the Treatment of Cancer: A Systematic Review and Meta-analysisDoni Bloomfield, Elvira D'Andrea, Sarosh Nagar, et al.
JAMA Network Open|October 12, 2019
Characteristics of Recent Generic Drug Approvals by the US Food and Drug AdministrationKuo Jiao, Ravi Gupta, Erin Fox, et al.
Journal of the National Cancer Institute|November 9, 2025
Patient and population impacts of multi-gene panel and pembrolizumab coverage in metastatic melanomaDeirdre Weymann, Emanuel Krebs, Samantha Pollard, et al.
Pageof 2